October 8, 2020
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) today released policy principles reaffirming the pharmaceutical distribution industry’s commitment to ensuring — in partnership with federal and state governments — the safe and efficient distribution of COVID-19 vaccines once they are approved by the Food and Drug Administration.
HDA highlights four priority areas for vaccine distribution:
“Our industry is committed to working closely with all levels of government and leveraging strong relationships across the supply chain in our continued response to COVID-19,” said HDA President and CEO Chester “Chip” Davis, Jr. “Distributors have the experience, infrastructure and relationships to support the distribution of a COVID-19 vaccine. We stand ready to leverage our logistics expertise and maximize the efficiencies of the existing distribution networks to deliver vaccines and therapeutics safely and securely to points of administration across the country.”
View the principles document.
For additional information and resources on pharmaceutical distributors’ response to COVID-19, visit www.hda.org/covid19.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.